Growth Hormone Releaser Attenuates β-Amyloid (1 - 42)-Induced Memory Impairment in Mice
Accumulating evidence indicates that growth hormone (GH) might be effective at preventing the development of Alzheimer's disease. However, exogenous GH treatment has exhibited side effects for clinical application; thus supplementation with amino acids to promote the release of GH could be a po...
Saved in:
Main Authors: | Eun-Joo Shin (Author), Jin Hyeong Jhoo (Author), Toshitaka Nabeshima (Author), Wang-Kee Jhoo (Author), Myung Sang Kwon (Author), Yong Kwang Lim (Author), Jong Seok Chae (Author), Myung Eun Jung (Author), Seok Joo Park (Author), Kyung Jin Jang (Author), Hyoung-Chun Kim (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2005-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Growth Hormone-Releaser Diet Attenuates β-Amyloid(1-42)-Induced Cognitive Impairment via Stimulation of the Insulin-Like Growth Factor (IGF)-1 Receptor in Mice
by: Eun-Joo Shin, et al.
Published: (2009) -
Treatment of Reflex sympathetic dystrophy with Bee venom -Using Digital Infrared Thermographic Imaging-
by: Myung-jang Lim, et al.
Published: (2006) -
Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer's Disease
by: Heeyoung Kang, et al.
Published: (2021) -
Long-Lasting Exendin-4 Fusion Protein Improves Memory Deficits in High-Fat Diet/Streptozotocin-Induced Diabetic Mice
by: Kyung-Ah Park, et al.
Published: (2020) -
Amyloid Pathology and Protein Kinase C (PKC): Possible Therapeutics Effects of PKC Activators
by: Ana Olariu, et al.
Published: (2005)